NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Date

 

Attendees 

Committee Member 

Present 

Absent 

Gina Kuffel 

X 

  

Toby Hecht 

 X 

 

Paula Jacobs 

Needs to leave at 3:30 

  

Gregory Tawa 

X 

  

James Dattilo 

X 

  

Shaying Zhao 

X 

  

Warren Kibbe 

X 

  

Matthew Breen 

X 

  

Amy LeBlanc 

X 

 

Elaine Ostrander 

 

Out of office 

Connie Sommers 

X 

 

Roel Verhaak 

X 

 

Erika Berger 

X 

 

Dawn Duval 

 

X 

Renee Chambers 

X 

 

Heather Gardner 

 

Conflict, but will otherwise attend. 

Ralph Parchment 

X 

 

  

Goals 

  • Formulate scientific questions and use cases that can be used to interrogate longitudinal datasets that would justify the ingestion of such data into the ICDC. 

SharePoint Site 

https://nih.sharepoint.com/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups 

Agenda 

Item 

Who 

Talking Points 

Define short-term mission statement 

 

All 

  • Determine exactly what type of data we want to bring into the ICDC 
  • What benefit does the ICDC gain through these relationships 
  • Encourage groups to use the ICDC as a data repository 
  • Talk with Golden Retriever Lifetime study 

Define long-term mission statement 

 

All 

  • Provide sustainable recognition of the ICDC as a repository 
  • Collect environmentalfactors 

MAF GRLS 

Matthew 

Move this item to next meeting. 

New Task Order 

Ralph 

  • Dog Aging Project won’t be funded until 2025 by National Institute of Aging 
  • Golden Retriever Lifetime study (old vs. young dogs with cancer) 
  • Obtain biospecimens from newly diagnosed canines that are enrolled in longitudinal studies 
  • Relate to metadata that is being collected 
  • Show that this is feasible (12-15 dogs over the course of 18 months) 
  • We will work with PIs from the Dog Aging Project outside of the original grant to fund the testing that will be required to collect data for feasibility study 

 

 

Minutes (Not Verbatim) 

TH – The ICDC is unique because we are enabling comparative oncology studies. The idea of getting data that can be of use as a model for human cancer. We are not competing with anyone in this spaceThere are many groups out there doing biopsies before and after treatment or from lack of response, resistance to therapy etc. That would really inform human studies. That is the major way that we can groups to use the ICDC.  

...

EB – There is a lot of DNA techniques being leveraged on pedigree dogs. 

 

 

  

  

  

Action items 

  •  Toby to work with Ralph to generate a letter that can be sent out to various Vet/Med Schools. 
  •  

...

  • Gina to bring the conversation about assessing longitudinal data submission to the DGAB.